Finance

Lists
Why is CRBU up 7,97%?
Dive Deeper
CRBU:NASDAQ
Caribou Biosciences Inc
US$0,50
+7,97%
(+0,037) 1D
US$0,50
+0,93% (+0,0046)
After hours
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBU...
Open
US$0,45
High
US$0,51
Low
US$0,44
Mkt. cap
53,29 ລ້ານ
Avg. vol.
3,40 ລ້ານ
Volume
5,25 ລ້ານ
52-wk high
US$3,53
52-wk low
US$0,44
EPS
US$-1,08
Beta
2,31
Shares outstanding
107,21 ລ້ານ
No. of employees
97
Open
US$0,45
High
US$0,51
Low
US$0,44
Mkt. cap
53,29 ລ້ານ
Avg. vol.
3,40 ລ້ານ
Volume
5,25 ລ້ານ
52-wk high
US$3,53
52-wk low
US$0,44
EPS
US$-1,08
Beta
2,31
Shares outstanding
107,21 ລ້ານ
No. of employees
97
News stories
From web sources and news partners
About Caribou Biosciences Inc
CEO-
Employees97
Founded1 ມ.ກ. 2011
HeadquartersBerkeley, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitecariboubio.com
Analyst ratings
Based on 6 analysts giving stock ratings to CRBU in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CRBU in the last 3 months.
Highest
Current US$0,50
US$8,00 (+1.509,98%)
Average
US$3,75 (+654,68%)
Lowest
US$1,00 (+101,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Hold
Downgraded
-
-
10/08/2026
Daina Graybosch
Leerink Partners
Hold
Downgraded
US$1,00
+101,2%
10/07/2026
Luca Issi
RBC Capital
Hold
Downgraded
US$1,00
+101,2%
10/06/2026
Leah R. Cann
Brookline Capital Markets
Hold
Downgraded
-
-
10/06/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
US$5,00
+906,2%
08/14/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
US$8,00
+1.510%
08/13/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
US$13,00
+2.516,2%
03/09/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
US$7,00
+1.308,7%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$4,00
+705%
03/06/2026
William Maughan
Clear Street
Buy
Maintained
US$13,00
+2.516,2%
03/06/2026
Last report
13 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,24 / US$-0,31
+21,74%beat
Revenue / Est. (USD)
1,50 ລ້ານ / 2,25 ລ້ານ
-33,25%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
2,20 ລ້ານ
3,94 ລ້ານ
2,40 ລ້ານ
1,50 ລ້ານ
Cost of goods sold
22,40 ລ້ານ
23,82 ລ້ານ
20,61 ລ້ານ
18,94 ລ້ານ
Cost of revenue
22,40 ລ້ານ
23,82 ລ້ານ
20,61 ລ້ານ
18,94 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,20 ລ້ານ
8,58 ລ້ານ
8,07 ລ້ານ
7,90 ລ້ານ
Operating expense
9,20 ລ້ານ
8,58 ລ້ານ
8,07 ລ້ານ
7,90 ລ້ານ
Total operating expenses
31,60 ລ້ານ
32,39 ລ້ານ
28,68 ລ້ານ
26,84 ລ້ານ
Operating income
-29,40 ລ້ານ
-28,45 ລ້ານ
-26,28 ລ້ານ
-25,34 ລ້ານ
Other non operating income
-
42,00 ພັນ
-
-
EBT including unusual items
-27,55 ລ້ານ
-27,04 ລ້ານ
-25,08 ລ້ານ
-24,28 ລ້ານ
EBT excluding unusual items
-27,55 ລ້ານ
-27,04 ລ້ານ
-25,08 ລ້ານ
-24,28 ລ້ານ
Income tax expense
-
-550,00 ພັນ
-
-
Effective tax rate
-
2,03%
-
-
Other operating expenses
-
-
-
-
Net income
-27,55 ລ້ານ
-26,49 ລ້ານ
-25,08 ລ້ານ
-24,28 ລ້ານ
Net profit margin
-1.253,32%
-672,11%
-1.046,52%
-1.619,88%
Earnings per share
-
-
-0,26
-0,24
Interest and investment income
1,85 ລ້ານ
1,37 ລ້ານ
1,20 ລ້ານ
1,06 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
1,85 ລ້ານ
1,37 ລ້ານ
1,20 ລ້ານ
1,06 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,77 ລ້ານ
-27,77 ລ້ານ
-25,63 ລ້ານ
-24,71 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google